张海鹏 博士
教授,博士生导师
电子邮件: zhanghp@smu.edu.cn
电 话:020-61648165
通讯地址:广东省广州市白云区沙太南路1023号(510515)
个人简介
张海鹏,本科毕业于山东大学,博士毕业于中山大学,入选国家优青、广东省杰青、珠江科技新星等人才项目。张海鹏博士专注于溶瘤病毒疗法的应用基础研究,以通讯或第一作者在Science Translational Medicine、Nature Communications(两篇)、PNAS(两篇)、Cell Reports等国际权威杂志发表论文12篇,相关学术成果被《Nature Reviews》专题评述。作为主要发明人授权中国专利6项,国际专利3项,其中一项专利获2022年度中国专利银奖。
研究方向
溶瘤病毒疗法
研究关键词
恶性肿瘤、溶瘤病毒、肿瘤免疫治疗
malignant tumor,oncolytic virus,cancer immunotherapy
代表性论著
1. Chen, X.#, Liu, J.#, Li, Y.#, Zeng, Y., Wang, F., Cheng, Z., Duan, H., Pan, G., Yang, S., Chen, Y., Li, Q., Shen, X., Li, Y., Qin, Z., Chen, J., Huang, Y., Wang, X., Lu, Y., Shu, M., Zhang, Y., Wang, G., Li, K., Lin, X.*, Xing, F.*, and Zhang, H.*. IDH1 mutation impairs antiviral response and potentiates oncolytic virotherapy in glioma. Nature Communications. 2023, 14(6781)(通讯作者,IF:17,中科院小类1区)
2. Huang, Y.#, Wang, F.#, Lin, X.#, Li, Q., Lu, Y., Zhang, J., Shen, X., Tan, J., Qin, Z., Chen, J., Chen, X., Pan, G., Wang, X., Zeng, Y., Yang, S., Liu, J., Xing, F.*, Li, K.*, and Zhang, H.*. Nuclear VCP drives colorectal cancer progression by promoting fatty acid oxidation. PNAS. 2023, 120 (41) e2221653120. (通讯作者,IF:12,中科院小类1区)
3. Zhang, H.#, Li, K.#, Lin, Y.#, Xing, F., Xiao, X., Cai, J., Zhu, W., Liang, J., Tan, Y., Fu, L., Wang, F., Yin, W., Lu, B., Qiu, P., Su, X., Gong, S., Bai, X., Hu, J.*, and Yan, G.*. Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma. Science Translational Medicine. 2017, 9(404). (第一作者,IF:19,中科院小类1区). Highlighted in Science Translational Medicine. Comments in Nature Reviews | gastroenterology&hepatology.
4. Wang, F.#, Qi, Q.#, Qin, B.#, Wang, Y., Huang, Y., Li, Q., Shen, X., Wang, X., Yang, S., Pan, G., Chen, J., Qin, Z., Chen, X., Yang, Y., Zeng, Y., Liu, J., Li, Y., Li, Y., Cheng, Z., Lin, X., Xing, F., Zhang, Y., Wang, G., Li, K.*, Jiang, Z.*, and Zhang, H.*. Targeting VCP potentiates immune checkpoint therapy for colorectal cancer. Cell Reports. 2023, 42(113318). (通讯作者,IF:9.9,中科院小类2区)
5. Xiao, X.#, Liang, J.#, Huang, C., Li, K., Xing, F., Zhu, W., Lin, Z., Xu, W., Wu, G., Zhang, J., Lin, X., Tan, Y., Cai, J., Hu, J., Chen, X., Huang, Y., Qin, Z., Qiu, P., Su, X., Chen, L., Lin, Y. *, Zhang, H.*, and Yan, G.*. DNA-PK inhibition synergizes with oncolytic virus M1 by inhibiting antiviral response and potentiating DNA damage. Nature Communications. 2018, 9(1):4342.(共同通讯作者,IF:17,中科院小类1区)
6. Li, K. #, Zhang, J. #, Lyu H. #, Yang J. #, Wei, W., Wang, Y., Luo, H., Zhang, Y., Jiang, X., Yi, H., Wang, M., Zhang, C., Wu, K., Xiao, L., Wen, W., Xu, H., Li, G., Wan, Y., Yang, F., Yang, R., Fu, X., Qin, B., Zhou, Z. *, Zhang, H*., Lee, M. *. CSN6-SPOP-HMGCS1 Axis Promotes Hepatocellular Carcinoma Progression via YAP1 Activation. Advanced Science. 2024(共同通讯作者,IF:16.7,中科院小类1区)
7. Qin, Z.#, Huang, Y.#, Li, Z.#, Pan, G., Zheng, L., Xiao, X., Wang, F., Chen, J., Chen, X., Lin, X., Li, K., Yan, G., Zhang, H.*, and Xing, F.*. Glioblastoma Vascular Plasticity Limits Effector T-cell Infiltration and Is Blocked by cAMP Activation. Cancer Immunology Research. 2023, 11(10):1351-1366. (共同通讯作者,IF:12.1,中科院小类1区)
8. Li, K.#, Hu, C.#, Xing, F.#, Gao, M., Liang, J., Xiao, X., Cai, J., Tan, Y., Hu, J., Zhu, W., Yin, W., Li, Y., Chen, W., Lu, B., Mai, J., Qiu, P., Su, X., Yan, G., Zhang, H.*, and Lin, Y.*. Deficiency of the IRE1alpha-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1. Journal of Virology. 2018, 92(6). (共同通讯作者,IF:4.9,中科院小类2区)
9. Tan, Y. #, Lin, Y. #, Li, K., Xiao, X., Liang, J., Cai, J., Guo, L., Li, C., Zhu, W., Xing, F., Mai, J., Gu, J., Tan, X., Yin, W., Lu, B., Qiu, P., Su, X., Gao, M., Hu, J., He, S., Lu, L., Gong, S., Yan, G., and Zhang, H.*. Selective Antagonism of Bcl-xL Potentiates M1 Oncolysis by Enhancing Mitochondrial Apoptosis. Human Gene Therapy. 2018, 29(8):950-961.(通讯作者,IF:4.7,中科院小类2区)
10. Lin, Y. #, Zhang, H.#, Liang, J.#, Li, K., Zhu, W., Fu, L., Wang, F., Zheng, X., Shi, H., Wu, S., Xiao, X., Chen, L., Tang, L., Yan, M., Yang, X., Tan, Y., Qiu, P., Huang, Y., Yin, W., Su, X., Hu, H., Hu, J.*, and Yan, G.*. Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancers. PNAS. 2014, 111(42):E4504-4512.(共同第一作者,IF:12,中科院小类1区)
11. Li, K.#, Zhang, H.#, Qiu, J., Lin, Y., Liang, J., Xiao, X., Fu, L., Wang, F., Cai, J., Tan, Y., Zhu, W., Yin, W., Lu, B., Xing, F., Tang, L., Yan, M., Mai, J., Li, Y., Chen, W., Qiu, P., Su, X., Gao, G., Tai, P. W., Hu, J.*, and Yan, G.*. Activation of Cyclic Adenosine Monophosphate Pathway Increases the Sensitivity of Cancer Cells to the Oncolytic Virus M1. Molecular Therapy. 2016, 24(1):156-165.(共同第一作者,IF:12.6,中科院小类1区)
12. Zhang, H.#, Lin, Y.#, Li, K., Liang, J., Xiao, X., Cai, J., Tan, Y., Xing, F., Mai, J., Li, Y., Chen, W., Sheng, L., Gu, J., Zhu, W., Yin, W., Qiu, P., Su, X., Lu, B., Tian, X., Liu, J., Lu, W., Dou, Y., Huang, Y., Hu, B., Kang, Z., Gao, G., Mao, Z., Cheng, S. Y., Lu, L., Bai, X. T., Gong, S., Yan, G., and Hu, J.*. Naturally Existing Oncolytic Virus M1 Is Nonpathogenic for the Nonhuman Primates After Multiple Rounds of Repeated Intravenous Injections. Human Gene Therapy. 2016, 27(9):700-711.(第一作者,IF:4.7,中科院小类2区)
代表性课题
1. 国家自然科学基金-优秀青年科学基金项目(82422073),2025/01~2027/12,主持;
2. 国家自然科学基金-面上项目(81972605),2020/01~2023/12,主持;
3. 国家自然科学基金-青年科学基金项目(81503088),2016/01~2018/12,主持;
4. 广东省自然科学基金-杰出青年项目(2021B1515020067),2021/01~2024/12,主持;
5. 广州市科技计划项目-珠江科技新星专项(201906010069),2019/04~2021/03,主持;
6.广州市科技计划-科技菁英“领航”项目(2024A04J6407),2024/04~2027/03,主持;
7. 广东省自然科学基金-博士启动(2016A030310160),2016/06~2019/06,主持;
8. 南方医科大学高层次人才引进启动基金,2024/04-2027/03,主持.
学术任职
1. 中国药理学会抗炎免疫药理学专业委员会 委员
2. 中国药理学会临床药理学专业委员会 青年委员
3. 中国药理学会生化与分子药理学专业委员会 青年委员
执教课程(课程及教材建设)
1. 药理学
2. 高等药理学
荣誉奖励
2024,国家优青
2021,广东省杰青
2019,珠江科技新星